Diamyd Medical sets up vaccine manufacturing facility in Umeå

Diamyd Medical is setting up a new manufacturing facility in Umeå, Sweden, to produce recombinant GAD65 for its diabetes vaccine Diamyd. Initial investments are estimated at approximately SEK 20 million (about USD 2 million).

“The importance of being in control of your own manufacturing process has never been higher.”prnewswire.com

• 1 source
• prnewswire.comDiamyd Medical Opens up for Vaccine Manufacturing in Umeå, SwedenDiamyd Medical ABApr 16, 2020

Summarized from public sources; check the original articles before acting on it.